1. Home
  2. KYMR vs CACC Comparison

KYMR vs CACC Comparison

Compare KYMR & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$72.35

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$497.91

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
CACC
Founded
2015
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.2B
IPO Year
2020
1992

Fundamental Metrics

Financial Performance
Metric
KYMR
CACC
Price
$72.35
$497.91
Analyst Decision
Strong Buy
Hold
Analyst Count
24
2
Target Price
$105.96
$485.00
AVG Volume (30 Days)
740.7K
162.2K
Earning Date
02-26-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
151.44
EPS
N/A
37.89
Revenue
$43,735,000.00
$1,232,900,000.00
Revenue This Year
$18.71
$154.47
Revenue Next Year
N/A
$1.57
P/E Ratio
N/A
$13.15
Revenue Growth
N/A
45.72
52 Week Low
$19.45
$401.90
52 Week High
$103.00
$560.00

Technical Indicators

Market Signals
Indicator
KYMR
CACC
Relative Strength Index (RSI) 47.75 64.97
Support Level $70.00 $431.71
Resistance Level $72.86 $454.52
Average True Range (ATR) 3.44 16.51
MACD 0.04 1.69
Stochastic Oscillator 57.69 98.50

Price Performance

Historical Comparison
KYMR
CACC

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

Share on Social Networks: